Statements (24)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:biotechnology
|
gptkbp:CEO |
gptkb:Barry_Greene
|
gptkbp:collaboratedWith |
gptkb:Biogen
|
gptkbp:country |
gptkb:United_States
|
gptkbp:developedBy |
antidepressant medications
treatments for major depressive disorder treatments for postpartum depression |
gptkbp:focusesOn |
neurological disorders
neuropsychiatric disorders central nervous system disorders |
gptkbp:foundedIn |
2010
|
gptkbp:founder |
gptkb:Jeffrey_Jonas
|
gptkbp:headquartersLocation |
gptkb:Cambridge,_Massachusetts,_United_States
|
https://www.w3.org/2000/01/rdf-schema#label |
Sage Therapeutics
|
gptkbp:industry |
gptkb:biotechnology
|
gptkbp:notableProduct |
gptkb:Zulresso
gptkb:Zurzuvae |
gptkbp:numberOfEmployees |
over 400
|
gptkbp:publiclyTraded |
true
|
gptkbp:stockSymbol |
gptkb:SAGE
|
gptkbp:tradedOn |
gptkb:NASDAQ:SAGE
|
gptkbp:website |
https://www.sagerx.com/
|
gptkbp:bfsParent |
gptkb:Polaris_Partners
|
gptkbp:bfsLayer |
4
|